Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 6: Want to learn pickleball? A new recreational facility could be coming to Raleigh. The new renderings on this $125 million project
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
1,179.31
+3.98 (+0.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Regeneron Pharmaceuticals
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
38
39
Next >
7 Best Biotech Stocks to Buy in July 2022
July 08, 2022
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.
Via
InvestorPlace
Is Merck Stock A Buy Amid Reports It Could Buy Seagen For $40 Billion?
July 07, 2022
Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now?
Via
Investor's Business Daily
Biotechs Say ESG Is Core To Their Mission; Do Investors Believe Them?
July 07, 2022
The biotech industry is trying to catch the ESG investing bug. But that doesn't mean investors are giving it credit, executives say.
Via
Investor's Business Daily
Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names
July 06, 2022
Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.
Via
Investor's Business Daily
Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis
June 24, 2022
Via
Benzinga
FDA Accepts Regeneron, Sanofi's Filing For Review In Skin Disease
May 31, 2022
The U.S.
Via
Benzinga
Regeneron's Evkeeza Reduces Bad Cholesterol By 48% In Children Aged 5-11 Years
May 23, 2022
Via
Benzinga
Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying
July 06, 2022
Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.
Via
Investor's Business Daily
This Foreboding Sign Looms Over Regeneron Pharmaceuticals's Chart
July 05, 2022
If history is any guide, there may be trouble ahead for shares of Regeneron Pharmaceuticals (NASDAQ:REGN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish...
Via
Benzinga
7 Best Healthcare Stocks to Buy Now
July 04, 2022
The move toward treating DNA as akin to a programming language is just getting started, but you can start profiting on healthcare stocks now.
Via
InvestorPlace
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
July 01, 2022
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.
Via
Benzinga
U.S. FDA Accepts Regeneron's Diabetic Retinopathy Candidate Submission For Review
June 29, 2022
The U.S. Food and Drug Administration (FDA) has accepted Regeneron Pharmaceuticals’ (NASDAQ: REGN) supplemental Biologics License Application (sBLA) of EYLEA (aflibercept) Injection for review in...
Via
Benzinga
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
June 27, 2022
More than four in 10 people in a recent survey knew of someone with long Covid.
Via
Investor's Business Daily
Regeneron Pharmaceuticals Whale Trades Spotted
June 17, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Regeneron Pharmaceuticals. Looking at options history for Regeneron Pharmaceuticals (NASDAQ:REGN) we detected 34 strange...
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,800 Today
June 15, 2022
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 10 years by 6.25% on an annualized basis producing an average annual return of 17.08%. Currently, Regeneron...
Via
Benzinga
Regeneron Pharmaceutical Stock Sees RS Rating Jump To 82
June 08, 2022
Looking for the best stocks to buy? Focus on those with rising relative price strength, such as Regeneron Pharmaceutical stock.
Via
Investor's Business Daily
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
June 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Sunshine Biopharma States It Is Developing COVID Antiviral That Could Play Important Role In Treating Endemic COVID
June 08, 2022
Image provided by Pexels
Via
Benzinga
U.S. FDA Approves Regeneron And Sanofi's Lead Drug For Skin Inflammation In Children
June 07, 2022
The U.S.
Via
Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
June 05, 2022
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.
Via
Benzinga
Stock Market Rally Falls As Fed Signals More Big Rate Hikes; Salesforce, Tesla In Focus: Weekly Review
June 03, 2022
Stocks fell modestly on hawkish Fed comments, but the Nasdaq held its 21-day line.
Via
Investor's Business Daily
Markets Rise Amid Strength In Tech, Software
June 02, 2022
U.S. indices finished Thursday’s trading session higher. Overall tech and software sector strength as well as strong first-quarter results from Mongodb Inc (NASDAQ: MDB) lifted markets higher for the...
Via
Benzinga
Regeneron Pharmaceuticals Dives On $1.1 Billion Deal To Rival Merck In Cancer
June 02, 2022
Regeneron secured the global rights to Sanofi-partnered Libtayo.
Via
Investor's Business Daily
Regeneron Pharmaceuticals Whale Trades Spotted
June 02, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Regeneron Pharmaceuticals. Looking at options history for Regeneron Pharmaceuticals (NASDAQ:REGN) we detected 11 strange...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
May 31, 2022
May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,...
Via
Benzinga
7 Analysts Have This to Say About Regeneron Pharmaceuticals
May 31, 2022
Over the past 3 months, 7 analysts have published their opinion on Regeneron Pharmaceuticals (NASDAQ:REGN) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
NASDAQ:REGN Investor Notice: Investigation over Potential Wrongdoing at Regeneron Pharmaceuticals, Inc.
May 31, 2022
San Diego, CA -- (SBWIRE) -- 05/31/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Regeneron Pharmaceuticals, Inc.
Via
SBWire
As COVID Subsidies, Here are 8 Infectious Diseases That Could Emerge As Potent Threats
May 30, 2022
The COVID-19 pandemic that emerged in early 2020 doesn't seem to have run its course. Daily average cases, though have declined notably, stood at 110,084 in the U.S. as of Thursday, according to data...
Via
Benzinga
United Airlines Leads Five Stocks Breaking Resistance As Market Rebounds
May 28, 2022
United Airlines headlines five stocks to watch for the week ahead.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
May 23, 2022
Via
Benzinga
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.